44th Annual J.P. Morgan Healthcare Conference (IMAGE)
Caption
Leadership from Insilico Medicine (“Insilico”, HKEX:03696), a world-leading artificial intelligence (AI)-driven drug discovery company, will attend the 44th Annual J.P. Morgan Healthcare Conference Jan. 12-15, 2026, in San Francisco
Credit
Insilico Medicine
Usage Restrictions
None
License
Original content